Loading company…
Surefire Medical develops the PEDD drug delivery system for cancer treatment, based in Westminster, US.
Surefire Medical, Inc. develops therapeutic medical devices to improve cancer treatment, led by its Pressure-Enabled Drug Delivery (PEDD) system, which sells to hospitals and oncology clinics. Founded in 2009 and headquartered in Westminster, US, the company is led by CEOs Brenda Zimmerman-Vertin and Mary Szela. It raised USD 12.8 mn in Series D funding led by ORI Capital in March 2017, and the PEDD system has been used in over 18,000 procedures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in